• 2019
  Mateo M, Reynard S, Carnec X, Journeaux A, Baillet N, Schaeffer J, Picard C, Legras-Lachuer C, Allan R, Perthame E, Hillion KH, Pietrosemoli N, Dillies MA, Barrot L, Vallve A, Barron S, Fellmann L, Gaillard JC, Armengaud J, Carbonnelle C, Raoul H, Tangy F, Baize S, Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot, Sci Transl Med 2019 Oct;11(512).
• 2019
  Mateo M, Picard C, Sylla Y, Kamo E, Odegue D, Journeaux A, Kan SK, Money M, Coulibaly DN, Koffi E, Meite S, Akran V, Kadjo H, Adjogoua E, Kakou SN, Baize S, Dosso M, Fatal Case of Lassa Fever, Bangolo District, Côte d’Ivoire, 2015, Emerging Infect. Dis. 2019 Sep;25(9):1753-1756.
• 2019
  Baillet N, Krieger S, Journeaux A, Caro V, Tangy F, Vidalain PO, Baize S, Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses, Viruses 2019 03;11(3).
• 2019
  Schaeffer J, Reynard S, Carnec X, Pietrosemoli N, Dillies MA, Baize S, Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus, Viruses 2019 03;11(3).
• 2019
  Reynard S, Journeaux A, Gloaguen E, Schaeffer J, Varet H, Pietrosemoli N, Mateo M, Baillet N, Laouenan C, Raoul H, Mullaert J, Baize S, Immune parameters and outcomes during Ebola virus disease, JCI Insight 2019 Jan;4(1).
• 2018
  Schaeffer J, Carnec X, Reynard S, Mateo M, Picard C, Pietrosemoli N, Dillies MA, Baize S, Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells, PLoS Pathog. 2018 11;14(11):e1007430.
• 2018
  Madelain V, Baize S, Jacquot F, Reynard S, Fizet A, Barron S, Solas C, Lacarelle B, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X, Guedj J, Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies, Nat Commun 2018 10;9(1):4013.
• 2018
  Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S, A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins, J. Virol. 2018 06;92(12).
• 2017
  Tartour K, Nguyen XN, Appourchaux R, Assil S, Barateau V, Bloyet LM, Burlaud Gaillard J, Confort MP, Escudero-Perez B, Gruffat H, Hong SS, Moroso M, Reynard O, Reynard S, Decembre E, Ftaich N, Rossi A, Wu N, Arnaud F, Baize S, Dreux M, Gerlier D, Paranhos-Baccala G, Volchkov V, Roingeard P, Cimarelli A, Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs, PLoS Pathog. 2017 09;13(9):e1006610.
• 2017
  Subtil F, Delaunay C, Keita AK, Sow MS, Touré A, Leroy S, Msellati P, Magassouba N, Baize S, Raoul H, Ecochard R, Barry M, Delaporte E, Etard JF, , Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea, Clin. Infect. Dis. 2017 Jun;64(12):1788-1790.
• 2017
  Vernet MA, Reynard S, Fizet A, Schaeffer J, Pannetier D, Guedj J, Rives M, Georges N, Garcia-Bonnet N, Sylla AI, Grovogui P, Kerherve JY, Savio C, Savio-Coste S, de Séverac ML, Zloczewski P, Linares S, Harouna S, Abdoul BM, Petitjean F, Samake N, Shepherd S, Kinda M, Koundouno FR, Joxe L, Mateo M, Lecine P, Page A, Tchamdja TM, Schoenhals M, Barbe S, Simon B, Tran-Minh T, Longuet C, L'Hériteau F, Baize S, Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea, JCI Insight 2017 03;2(6):e88864.
• 2017
  Nguyen TH, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM, Baize S, Sissoko D, Pastorino B, Rodallec A, Piorkowski G, Carazo S, Conde MN, Gala JL, Bore JA, Carbonnelle C, Jacquot F, Raoul H, Malvy D, de Lamballerie X, Mentré F, , Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted, PLoS Negl Trop Dis 2017 02;11(2):e0005389.
• 2017
  Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK, Msellati P, Magassouba N, Baize S, Raoul H, Izard S, Kpamou C, March L, Savane I, Barry M, Delaporte E, , Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study, Lancet Infect Dis 2017 05;17(5):545-552.
• 2016
  Hereth-Hebert E, Bah MO, Etard JF, Sow MS, Resnikoff S, Fardeau C, Toure A, Ouendeno AN, Sagno IC, March L, Izard S, Lama PL, Barry M, Delaporte E, , Ocular Complications in Survivors of the Ebola Outbreak in Guinea, Am. J. Ophthalmol. 2017 Mar;175:114-121.
• 2016
  van Griensven J, Edwards T, Baize S, , Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies, N. Engl. J. Med. 2016 12;375(23):2307-2309.
• 2016
  Sow MS, Etard JF, Baize S, Magassouba N, Faye O, Msellati P, Touré A, Savane I, Barry M, Delaporte E, , New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors, J. Infect. Dis. 2016 11;214(10):1475-1476.
• 2016
  Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Munoz VC, Doumbouya L, Harouna S, Kighoma PM, Koundouno FR, Lolamou R, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Uwamahoro MG, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, de Sainte Fare EB, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Duverger TA, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, , Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea, PLoS Med. 2016 Apr;13(4):e1002009.
• 2016
  Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna , Kighoma PM, Koundouno FR, Réné Lolamou , Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, , Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea, PLoS Med. 2016 Mar;13(3):e1001967.
• 2016
  van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N, , Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea, N. Engl. J. Med. 2016 Jan;374(1):33-42.
• 2015
  Salvetti A, Baize S, [Viral zoonoses and emergence: research is just starting], Med Sci (Paris) 2015 Dec;31(12):1055-6.
• 2015
  Sagui E, Janvier F, Baize S, Foissaud V, Koulibaly F, Savini H, Maugey N, Aletti M, Granier H, Carmoi T, Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement, Clin. Infect. Dis. 2015 Nov;61(10):1627-8.
• 2015
  Baize S, Towards deep insight into Ebola virus disease, Lancet Infect Dis 2015 Sep;15(9):991-992.
• 2015
  Baize S, Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus, Curr Opin Virol 2015 Feb;10:70-6.
• 2015
  Reusken C, Niedrig M, Pas S, Anda P, Baize S, Charrel R, Di Caro A, Drosten C, Fernandez-Garcia MD, Franco L, Gunther S, Leparc-Goffart I, Martina B, Pannetier D, Papa A, Sanchez-Seco MP, Vapalahti O, Koopmans M, Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014, J. Clin. Virol. 2015 Jan;62:124-34.
• 2014
  Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S, Berthet N, Blinkova O, Brister JR, Clawson AN, Fair J, Gabriel M, Garry RF, Gire SK, Goba A, Gonzalez JP, Günther S, Happi CT, Jahrling PB, Kapetshi J, Kobinger G, Kugelman JR, Leroy EM, Maganga GD, Mbala PK, Moses LM, Muyembe-Tamfum JJ, N'Faly M, Nichol ST, Omilabu SA, Palacios G, Park DJ, Paweska JT, Radoshitzky SR, Rossi CA, Sabeti PC, Schieffelin JS, Schoepp RJ, Sealfon R, Swanepoel R, Towner JS, Wada J, Wauquier N, Yozwiak NL, Formenty P, Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014, Viruses 2014 Nov;6(11):4760-99.
• 2014
  Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y, Ebola: should we consider influenza vaccination?, Lancet 2014 Dec;384(9959):2023-4.
• 2014
  Reynard S, Russier M, Fizet A, Carnec X, Baize S, Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response, J. Virol. 2014 Dec;88(23):13923-7.
• 2014
  Russier M, Reynard S, Carnec X, Baize S, The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses, J. Virol. 2014 Dec;88(23):13811-20.
• 2014
  Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Günther S, Emergence of Zaire Ebola virus disease in Guinea, N. Engl. J. Med. 2014 Oct;371(15):1418-25.
• 2014
  Pannetier D, Reynard S, Russier M, Carnec X, Baize S, Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever, PLoS Negl Trop Dis 2014;8(1):e2637.
• 2012
  Russier M, Pannetier D, Baize S, Immune responses and Lassa virus infection, Viruses 2012 Nov;4(11):2766-85.
• 2012
  Russier M, Reynard S, Tordo N, Baize S, NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression, Eur. J. Immunol. 2012 Jul;42(7):1822-32.
• 2011
  Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M, Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages, J. Virol. 2011 Nov;85(22):12093-7.
• 2011
  Pannetier D, Reynard S, Russier M, Journeaux A, Tordo N, Deubel V, Baize S, Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus, J. Virol. 2011 Aug;85(16):8293-306.
• 2011
  Leroy EM, Becquart P, Wauquier N, Baize S, Evidence for Ebola virus superantigen activity, J. Virol. 2011 Apr;85(8):4041-2.
• 2010
  Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM, Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis, PLoS Negl Trop Dis 2010 Oct;4(10).
• 2010
  Baize S, Towards broad protection against Ebolaviruses, Future Microbiol 2010 Oct;5(10):1469-73.
• 2009
  Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H, Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys, J. Virol. 2009 Jun;83(11):5890-903.
• 2006
  Baize S, Pannetier D, Faure C, Marianneau P, Marendat I, Georges-Courbot MC, Deubel V, Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages, Microbes Infect. 2006 Apr;8(5):1194-202.
• 2005
  Baize S, A single shot against Ebola and Marburg virus, Nat. Med. 2005 Jul;11(7):720-1.
• 2004
  Pannetier D, Faure C, Georges-Courbot MC, Deubel V, Baize S, Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection, J. Virol. 2004 Oct;78(19):10516-24.
• 2004
  Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V, Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells, J. Immunol. 2004 Mar;172(5):2861-9.
• 2003
  Baize S, Deubel V, [Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates], Med Sci (Paris) 2003 Dec;19(12):1183-4.